免疫原性细胞死亡
医学
癌症研究
背向效应
免疫系统
高强度聚焦超声
免疫检查点
免疫疗法
细胞凋亡
聚焦超声
癌症
T细胞
流式细胞术
病理
PD-L1
细胞毒性T细胞
癌细胞
细胞
佐剂
癌症免疫疗法
生长抑制
前列腺癌
细胞生长
黑色素瘤
作者
Rui Tada,Taiki Yamaguchi,Takashi Kanno,Yoko Endo‐Takahashi,Mai Hayakawa,Yosuke Togashi,Shin Yoshizawa,Yoshiyuki Adachi,Yoichi Negishi
标识
DOI:10.1016/j.intimp.2025.115565
摘要
Cancer treatments are often associated with limitations such as invasiveness, harmful side effects, and limited success in distant metastases. High-intensity focused ultrasound (HIFU) presents a noninvasive method for destroying tumors; nonetheless, its use is mainly confined to localized cases. In this study, we applied a novel HIFU technology, termed Trigger HIFU sequence (“Trigger HIFU”), which not only effectively curtailed growth at the site of treatment, but also prevented tumor advancement in remote, untreated areas through immune-mediated abscopal effects. Using a mouse model with bilateral MC38 colon carcinoma, applying Trigger HIFU to tumors on the right flank caused a significant reduction in the growth of treated and untreated tumors on the left flank. The treated tumors underwent approximately a 75 % decrease in volume compared with the controls. Flow cytometry showed a notable increase in tumor-infiltrating CD8 + cytotoxic T and CD11c + dendritic cells in both the treated and untreated tumors. However, CD8 + T cell depletion eliminated the anti-tumor effects locally and at distant sites. Mechanistically, Trigger HIFU induces immunogenic cell death, characterized by apoptosis and the release of damage-associated molecular patterns, such as adenosine triphosphate and high mobility group box 1 protein. Moreover, combining Trigger HIFU with anti-programmed death-1 checkpoint inhibition enhances therapeutic efficacy beyond that of either treatment alone, indicating potential synergistic clinical applications. These findings extend beyond conventional HIFU by demonstrating systemic antitumor immune activation, thereby offering new possibilities for the treatment of metastatic disease through local intervention. • Trigger HIFU enhances immune-mediated antitumor effects. • CD8 + T cell-dependent abscopal effects suppress distant untreated tumors. • Combination with anti-PD-1 therapy significantly enhances systemic immune responses. • CD8 + cytotoxic T and CD11c + dendritic cells increase in treated and untreated tumors. • Trigger HIFU induces immunogenic cell death with apoptosis and DAMP release.
科研通智能强力驱动
Strongly Powered by AbleSci AI